GSK is teaming up with “Modern Family” stars Julie Bowen and Ty Burrell to help get out the messaging: “ask to be sure” about the risks of meningococcal disease. This disease is most prevalent amongst ...
GSK (GSK) reported better-than-expected financials for Q1 2026 on Wednesday as sales from its HIV and cancer medicines offset a sales decline for its general medicines, including its respiratory ...
GSK has finally called time on its pact with Mersana Therapeutics despite sinking $100 million to secure an option for an antibody-drug conjugate (ADC). That deal, signed back in 2022, centered on XMT ...
GSK (GSK) is preparing a high-stakes push into oncology, lining up five late-stage trials at once for a promising cancer drug as new CEO Luke Miels seeks to reshape the company’s historically cautious ...
GSK Plc is planning five simultaneous late-stage trials for a cancer drug it hopes will be a blockbuster, as new Chief Executive Officer Luke Miels tries to revitalize a company not known for its risk ...
GSK’s planned investment of up to $800 million in its campus near Marietta got a $9 million boost from a state Redevelopment Capital Assistance Program grant earlier this year. The grant is part of ...
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. LONDON — Building up its base of ...
Drugmaker GSK said it agreed to acquire Californian biopharmaceutical company RAPT Therapeutics for around $2.2 billion, a move set to bolster its respiratory, immunology and inflammation portfolio.
SAN FRANCISCO--(BUSINESS WIRE)--Noetik, an AI-native biotech company pioneering self-supervised machine learning and high-throughput spatial data to develop next-generation cancer therapeutics, ...
An experimental GSK drug in development for treating chronic hepatitis B now has results from two pivotal studies showing the therapy brought levels of the virus low enough to allow the immune system ...
GSK Plc said it won US approval for a drug to treat severe asthma, boosting its prospects as a potential blockbuster. The US Food and Drug Administration approved Exdensur as an add-on maintenance ...
GSK’s respiratory drug lineup spans a newly approved product for chronic obstructive pulmonary disease as well as therapeutic candidates in various stages of clinical development for treating this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results